Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze IONS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate IONS investment potential.

What is IONS stock price today?

Get real-time IONS stock price, historical data, and price charts on Financhill. Track IONS performance with our advanced analysis tools.

Is IONS a good investment?

Evaluate IONS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy IONS stock?

To buy IONS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of IONS?

View detailed market capitalization data and company valuation metrics for IONS on our comprehensive analysis page.

What is the P/E ratio of IONS?

Use our fundamental analysis tools to view IONS P/E ratio and compare valuation metrics with industry peers.

What are IONS earnings?

View IONS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Ionis Pharmaceuticals, Inc. 10K Form

Sell

IONS
Ionis Pharmaceuticals, Inc.

Last Price:

$75.64

Seasonality Move:

-4.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02	10Q	IONS/Ionis Pharmaceuticals, Inc. Quarterly
2023-08-09	10Q	IONS/Ionis Pharmaceuticals, Inc. Quarterly
2023-05-03	10Q	IONS/Ionis Pharmaceuticals, Inc. Quarterly
2022-11-09	10Q	IONS/Ionis Pharmaceuticals, Inc. Quarterly
2022-08-09	10Q	IONS/Ionis Pharmaceuticals, Inc. Quarterly
2022-05-04	10Q	IONS/Ionis Pharmaceuticals, Inc. Quarterly

Receive IONS News And Ratings

See the #1 stock for the next 7 days that we like better than IONS

IONS Financial Statistics

Sales & Book Value

Annual Sales:	$943.7M
Cash Flow:	$-160.4M
Price / Cash Flow:	0
Annual Sales:	$2.99
Price / Book:	25.55

Profitability

EPS (TTM):	-2.46670
Net Income (TTM):	$-381M
Gross Margin:	$915.4M
Return on Equity:	-67.97%
Return on Assets:	-12.4%

Ionis Pharmaceuticals, Inc. Earnings Forecast

Key Ionis Pharmaceuticals, Inc. Financial Ratios

The Gross Profit Margin over the past 36 years for IONS is 97.00%.
The Selling, General & Administrative Expenses for IONS have been equal to 41.74% of Gross Profit Margin.
The Research & Development expenses have been 96.76% of Revenue.
The Net Earning history of IONS is -40.41% of Total Revenues.
Per Share Earnings over the last 36 years have been positive in 17 years.

Ionis Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	IONS
CUSIP:	462222
Website:	ionis.com

Debt

Debt-to-Equity Ratio:	5.35
Current Ratio:	3.83
Quick Ratio:	3.51

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

IONS Technical Analysis vs Fundamental Analysis